SCHEMBL6045368

SCHEMBL6045368

O=C(O)c1ccccc2c3ccccc3nc1-2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
NR4A1 P22736 1/20 0.50
NR4A2 P43354 1/20 0.50
NR4A3 Q92570 1/20 0.50
ALDH1A1 P00352 3/20 0.49
PDE10A Q9Y233 3/20 0.49
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
DHODH Q02127 2/20 0.47
ALOX15 P16050 1/20 0.46
POLB P06746 2/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
RECQL P46063 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15101407 0.86 GRM2 (0.50) KDM4ERAB9AKMT2AALDH1A1
SCHEMBL4525351 0.82 DHODH (0.48) KDM4EKMT2AMEN1ALDH1A1PDE10A
SCHEMBL14936823 0.75 KDM4E (0.61) KDM4EKMT2AMEN1NR4A1NR4A2
SCHEMBL8324531 0.74 MEN1 (0.77) KDM4ERAB9AKMT2AMEN1ALDH1A1
SCHEMBL10513809 0.74 CAMKK1 (0.52) KDM4ERAB9AKMT2AMEN1ALDH1A1
SCHEMBL17559805 0.73 NSD2 (0.54) KDM4EKMT2AMEN1ALDH1A1LMNA
SCHEMBL7863345 0.73 LMNA (0.54) KDM4ERAB9AKMT2AMEN1NR4A1
SCHEMBL4492054 0.72 ADORA2A (0.47) KDM4ERAB9AKMT2AMEN1ALDH1A1
SCHEMBL18539204 0.71 NR4A1 (0.61) KDM4EKMT2ANR4A1NR4A2NR4A3
SCHEMBL29908923 0.71 ALDH1A1 (0.59) KDM4EKMT2ANR4A1NR4A2NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060074124-A1 Methods of treating a disorder IPSOL AG (LI) 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074124-A1 Methods of treating a disorder CPT1B, CYP27A1, CLN6 KDM4E 3776/4885RAB9A 1683/4885KMT2A 2722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.